Abstract Anesthesia/surgery could be associated with cognitive impairment and Alzheimer's disease neuropathogenesis. However, whether surgery under different anesthetics has different effects on cognitive function remains largely unknown. We therefore set out to compare effects of anesthetic isoflurane or desflurane plus surgery on cognitive function and hippocampus levels of synaptic marker (postsynaptic density-95 and synaptophysin) and ATP. Five-month-old AD Transgenic (Tg) (FAD5X) and wild-type male mice received isoflurane or desflurane plus abdominal surgery. We assessed cognitive function in Barnes maze and measured hippocampus levels of postsynaptic density-95, synaptophysin, and ATP in the mice. We determined whether vitamin K 2 could mitigate these anesthesia/surgery-induced changes. Isoflurane, but not desflurane, plus surgery increased escape latency and escape distance in Barnes maze probe test and reduced postsynaptic density-95, synaptophysin, and ATP levels as compared to control condition in AD Tg mice. Vitamin K 2 attenuated the anesthesia/surgery-induced changes in the AD Tg mice. These findings suggest that isoflurane, but not desflurane, plus surgery might induce cognitive impairment via causing brain energy deficits. Pending confirmative studies in both animals and humans suggest desflurane could be a better choice for AD patients when surgery is needed. Moreover, vitamin K 2 could treat cognitive deficiency associated with anesthesia and surgery.
Introduction
Clinical investigations suggest potential association between anesthesia/surgery and cognitive impairment [1] [2] [3] [4] [5] and Alzheimer's disease (AD) neuropathogenesis [6] [7] [8] [9] . However, findings that anesthesia/surgery is not associated with dementia also exists [10] [11] [12] [13] [14] . Interestingly, the majority of these studies did not specifically determine the effects of different anesthetics (e.g., isoflurane versus desflurane) on the cognitive function. Answering the question whether surgery under certain anesthetics (e.g., desflurane) are less associated with cognitive impairment than other anesthetics (e.g., isoflurane) would be important in the ultimate development of strategy to prevent postoperative cognitive impairment in AD patients (reviewed in [15] ).
Our previous studies have shown that anesthesia with isoflurane, but not with desflurane, can induce cognitive impairment in wild-type (WT) mice [16] . Moreover, such a difference could be due to the different effects of isoflurane and desflurane on mitochondrial function [16, 17] . Other studies also assessed the effects of anesthetic isoflurane and halothane on cognitive function in AD transgenic (Tg) mice [18] . However, these studies did not include surgery; thus, the outcomes may not be sufficient enough to promote clinical investigation to determine whether surgery under desflurane is less associated with cognitive impairment and/or dementia than surgery under isoflurane. Other studies show that surgery under brief general anesthesia [19] [20] [21] [22] [23] [24] [25] or under local anesthesia [26, 27] can induce cognitive impairment in rodents. But these studies did not use AD Tg mice and did not compare the effects of surgery under different anesthetics (e.g., isoflurane versus desflurane) on cognitive function in the rodents.
Our recent studies have established the system of abdominal surgery under anesthesia in mice [28, 29] . Thus, the objective of the current studies is to compare the effects of surgery under either isoflurane or desflurane on cognitive function in 5-month-old AD Tg (5XFAD) mice and age-matched WT mice to test a hypothesis that isoflurane, but not desflurane, plus surgery induces cognitive impairment in AD Tg mice.
Postsynaptic density 95 (PSD-95) [30, 31] and synaptophysin (SVP) [32] are markers of synapse in hippocampus. Therefore, we compared the effects of isoflurane or desflurane plus surgery on the hippocampus levels of PSD-95 and SVP, as well as ATP levels, as parts of the mechanistic investigation.
Finally, vitamin K 2 is a mitochondrial electron carrier and energy enhancer [33] and has neuroprotective effects [33] [34] [35] . We therefore assessed whether vitamin K 2 could mitigate the effects of anesthesia plus surgery on cognitive function, hippocampus levels of synaptic markers, and ATP in the mice.
Materials and Methods
Mice Anesthesia/Surgery and Treatment We performed all experiments in accordance with the National Institutes of Health guidelines and regulations. Massachusetts General Hospital (Boston, MA) Standing Committee on the Use of Animals in Research and Teaching has approved the animal protocol (Protocol Number 2006N000219). Efforts were made to minimize the number of animals used. The WT mice in the current studies were C57BL/6J mice (The Charles River Laboratories, Wilmington, MA). The AD transgenic mice were purchased from Jackson Lab (Bar Harbor, ME) (B6SJL Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas/Mmjax; Stock Number 006554) and maintained in our own lab. Standard genotype technique was used to confirm the condition of AD Tg mice. Both WT and AD Tg mice used in the studies were 5-month-old male mice. The AD Tg mice are APP/PS1 double transgenic mice with coexpression of five familial Alzheimer's disease (FAD) mutations (5XFAD) [36] . The amyloid deposition (and gliosis) in 5XFAD mice begins at 2 months of age and intraneuronal Aβ42 accumulation in these mice starts at 1.5 months of age [36] . Therefore, 5-month-old 5XFAD mice have developed sufficient AD neuropathogenesis. For the purpose of comparison, we employed same age (5-month-old) WT mice in the studies. We used male mice because there are no studies which exclusively used male mice to assess the effects of anesthesia and/or surgery on cognitive function. In addition, we had sufficient amounts of male AD Tg mice at the time of the experiments. We housed the mice in a controlled environment (20-22°C; 12 h of light/dark on a reversed light cycle) for 7 days prior to the studies. As demonstrated in Supplementary Fig. 1 , the mice were randomly assigned to isoflurane or desflurane anesthesia plus surgery (anesthesia/surgery) group or the control group. The anesthesia/surgery was started between 9:00 and 10:00 am. A simple laparotomy was performed under 1.4% isoflurane or 7.5% desflurane anesthesia. Specifically, anesthesia was induced and maintained with 1.4% isoflurane or 7.5% desflurane in 100% oxygen in a transparent acrylic chamber. Fifteen minutes after the induction, each of the mice was moved out of the chamber, and anesthesia (isoflurane or desflurane) was maintained via a cone device. One 16-gauge needle was inserted into the cone near the nose of the mouse to monitor the concentration of isoflurane. A longitudinal midline incision was made from the xiphoid to the 0.5-cm proximal pubic symphysis on the skin, abdominal muscles, and peritoneum. Then, the incision was sutured layer by layer with 5-0 Vicryl thread. At the end of the procedure, EMLA cream (2.5% lidocaine and 2.5% prilocaine) was applied to the incision wound, three times daily for 3 days to treat the pain associated with the incision. Our previous studies [26] have shown that there was no significant difference of pain threshold between the control and surgery mice at 24 h after the surgery. The procedure for each mouse lasted about 10 min, and the mouse was put back into the anesthesia chamber for up to 2 h to receive the rest of the same anesthesia (1.4% isoflurane or 7.5% desflurane in 100% oxygen). We used this combination of anesthesia and surgery in the studies because the abdominal surgery could potentiate the anesthesia neurotoxicity and this combination has been shown to induce cognitive impairment in our previous studies [28, 29] . The temperature of the anesthetizing chamber was controlled (DC Temperature Control System; FHC, Bowdoinham, Maine) to maintain the rectal temperature of the mice at 37 ± 0.5°C during the anesthesia/surgery. After recovering from the anesthesia, each mouse was returned to a home cage with food and water available ad libitum. The mice in the control group (food and water available ad libitum) were placed in their home cages with room air for 2 h, which was consistent with the condition of humans without anesthesia and surgery. Our previous studies found that neither this type of surgery [26, 27] nor anesthesia with 1.4% isoflurane [37] significantly disturbed the values of blood pressure and blood gas in the mice. EMLA was able to treat the pain associated with the surgery in the mice [26, 27] . In the interventional studies, vitamin K 2 (Sigma-Aldrich Inc., Natick, MA, Catalog Number, V9378) or coil oil (vehicle of vitamin K 2 ) was administered to the AD Tg mice via intraperitoneal injection daily for 9 days (8 days before the anesthesia/surgery day and then 30 min before the anesthesia/surgery on the procedure day). The dosage of vitamin K 2 (100 mg/kg/day) was selected according to the previous studies [35] .
Barnes Maze Test
We performed Barnes maze test using the methods described in other studies [38] [39] [40] [41] with modifications. Barnes maze is a circular open platform (about 90 center meter diameter) with 20 equally spaced holes (one of these holes connects with a small dark recessed chamber called escape box), located in a quiet area, and was surrounded by a dark curtain with four simple colored-paper shapes (square, circle, triangle, and star) as markers (Stoelting, Wood Dale, IL). A video hangs right above the platform which can capture the entire platform. The movement parameters (escape latency, escape distance, escape speed, escape errors, and time in target quadrant) of the mouse were monitored and analyzed via a video camera connected to the Any-Maze animal tracking system software (Stoelting Co., Wood Dale, IL) as described in previous studies [39, 42, 43] . The percent of time in the time in target quadrant corresponds to the time spent in 1/4 of the maze. We used the hidden-target hole protocol in the studies according to the methods described in previous studies [44, 45] . Specifically, the location of the target hole was fixed and was not marked by any intra-maze reference, which was located in the same position relative to the extramaze cues around the test room. This protocol refers the use of the spatial cues to find the hidden target, which is specific to the spatial reference-memory version of the Barnes maze task [44, 45] . We only measured the total errors and total latency in the current studies according to the methods described in the previous studies [46] [47] [48] [49] [50] . The Barnes maze test in the current studies included Barnes maze training test (day 1 to 7 before the anesthesia/surgery) and Barnes maze probe test (3, 7, 14, 21, 28, 35 , and 42 days after the anesthesia/surgery, respectively) (Supplementary Fig. 1 ). On day 8 before the anesthesia/surgery, all of the mice were habituated to the maze. During the habituation, the mouse was placed in the escape box for 2 min, then placed directly in the hole that led to the escape box and allowed to remain in the box for another 4 min. Finally, the mouse was placed under a bucket in the center of the circular platform and motivated to escape under the stimulation of bright light (200 W) and aversive noise (85 dB) and gently guided to the hole connecting to the escape box. Immediately after the mouse entered the tunnel between the hole and the escape box, the buzzer should be turned off. Each mouse was allowed to remain in the escape box for 1 min and then removed and placed back to the home cage. The Barnes maze training test (day 7 to day 1 before the anesthesia/surgery) consisted of two trials (3 min each trial and 15 min between the trials) for 7 days. Our pilot studies showed that the AD Tg mice had not learnt to find the escape hole at the end of 4-day training period because the AD Tg mice had impaired learning ability. Previous studies also suggest that 7-day training period may increase the learning performance in Barnes maze as compared to 4-day training period [43] . Therefore, we used the 7-, but not 4-, day training period in the current studies to better illustrate the potential difference in Barnes maze performance between the mice in control group and the mice in anesthesia/surgery groups. In each trial, the mouse was placed under a bucket in the center of the circular platform for 10 s and was allowed to escape under the same stimulation of light and aversive noise. Once reaching the escape box, the mouse was allowed to remain in the escape box for 1 min. The mouse was then removed and placed back to the home cage for 15 min of rest period before returning back for another trial. The values of the escape latency of the last training day served as the Barnes maze probe test baseline. After the training period, the mice had the anesthesia/surgery (day 0). Then, the mice had the Barnes maze probe test on days 3, 7, 14, 21, 28, 35, and 42 after the anesthesia/surgery, respectively ( Supplementary Fig. 1 ). The total time to find the escape box was recorded as escape latency. Moreover, the total path length of distance traveled (escape distance), mean speed (escape speed), the total error holes searched (escape errors), and the percentage of time spent in the target quadrant [time in target quadrant (%)] before the mice found the escape box in both probe test and training test were recorded. The increase in escape latency, escape distance, escape errors, and decrease in time in target quadrant in the Barnes maze suggests cognitive impairment of the mice [38] [39] [40] [41] . The decreases in escape speed suggest impairment of locomotor activity. We used the percentage of time in the target quadrant rather than the target preference in the current studies according to the previous studies [42, 51] . Between each test, the Barnes maze was cleaned with 75% alcohol solution to avoid olfactory cues.
Brain Tissue Harvest, Lysis, and Protein Quantification At the end of last behavior test on day 42, each of mice was killed by decapitation. The brain tissues (hippocampus) of the mice were harvested and subjected to Western blot analysis. The brain tissues (cortex) of the mice were also harvested and subjected to enzyme-linked immunosorbent assay (ELISA) Aβ measurement. Different groups of mice were used for the studies to determine brain ATP levels. The brain tissues (hippocampus) of the mice were harvested immediately at the end of the anesthesia/surgery for the measurement of brain ATP levels [28] . We homogenized the harvested brain tissues on ice using immunoprecipitation buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, and 0.5% Nonidet P-40) plus protease inhibitors (1 mg/ml aprotinin, 1 mg/ml leupeptin, and 1 mg/ml pepstatin A). The lysates were then collected and centrifuged at 10,000 rpm for 5 min at 4°C. Total protein levels were quantified with bicinchoninic acid (BCA) protein assay kit (Pierce, Iselin, NJ) as described in our prior studies [16] .
Western Blot Analysis The PSD-95 antibody (95 kDa, 1:1000, Cell Signaling, Danvers, MA) and SVP antibody (38 kDa, 1:1000, Abcam, Cambridge, MA) were used in the Western blot analysis to detect the levels of PSD-95 and SVP, respectively. The quantification of Western blot was performed as described in our previous studies [16, 37] . Specifically, signal intensity was analyzed using image analysis program Quantity One (Bio-Rad, Hercules, CA). The Western blots were then quantified in two steps. First, we used β-actin levels to normalize protein levels (e.g., determining the ratio of PSD-95 to β-actin amount) and control for loading differences in the total protein amount. Second, we presented the changes in protein levels from the mice undergoing anesthesia/surgery as a percentage of those in the mice from control group. Changes (100%) of protein levels refer to control levels for the purpose of comparison with experimental conditions.
ATP Measurement
The levels of ATP in the hippocampus of mice were determined by the ATP Colorimetric/Fluorometric Assay Kit following the protocol provided by the manufacturer (Biovision Inc., Milpitas, CA) and the methods described in previous studies [28, [52] [53] [54] . Briefly, we homogenized the harvested hippocampus tissues on ice by using 100 μL ATP assay buffer, then we took 80 μL sample and 20 μL ice-cold perchloric acid and put them in a new tube, placed the tube on ice for 5 min, and mixed well by vortex. We centrifuged the samples for 2 min at the speed of 13,000×g. Of the supernatant, 76 μL was transferred to a new tube. Then, we added 4 μL ice-cold neutralization solution to the tube, mixed to neutralize the sample placed on ice, and the sample tube was opened to air for 5 min. We then centrifuged the tube at 13,000×g for 2 min for bicinchoninic acid assay. We diluted 10 μL of the ATP standard with 90 μL distilled water to generate 1 mM ATP standard and mixed it well. We added sample and ATP assay buffer (1 mM) to 50 μL/well in the 96-well plate. Finally, we added reaction mix of 50 μL to each well containing the ATP standard or test samples. The reaction mix includes 44 μL ATP assay buffer, 2 μL ATP probe, 2 μL ATP converter, and 2 μL developer. We mixed the samples and incubated them for 30 min at room temperature (avoiding light). Finally, we measured the absorbance (OD 570 nm) in a micro-plate reader to calculate the ATP level.
Enzyme-Linked Immunosorbent Assay Aβ Measurement
The levels of Aβ42 in the cortex of mice were measured by the mouse Aβ42 immunoassay kits (Invitrogen, San Francisco, CA, Catalog Number KMB 3441) according to the manufacturer's instructions and the methods described in our previous studies [27] .
Statistics Data of escape latency, escape distance, escape speed, escape errors, and time in target quadrant were expressed as mean ± standard error of mean (SEM). Data of other variables were expressed as mean ± standard deviation. The number of samples was 10-12 per group for the behavior test and 6 per group for the biochemical studies. The power calculation was performed using information collected from a preliminary study that was conducted under the same conditions. Based on the preliminary data, assuming a two-sided Student's t test, samples of 6 and 10 for each control and treatment group for the biochemistry and behavior studies, respectively, would lead to 90% power at the 0.05 alpha level. In the Barnes maze studies, interaction between time and group factors in a two-way ANOVA with repeated measurements was used to analyze the difference of memory curves (e.g., based on escape latency). Bonferroni method was used in post hoc analyses to compare the difference in escape latency, escape distance, escape speed, escape errors, and time in target quadrant for each testing day. A two-way ANOVA was used to determine the interaction between group and treatment on the levels of PSD-95, SVP, and ATP, followed by Bonferroni test for post hoc comparisons. PSD-95, SVP, and ATP levels were presented as a percentage of those of the control group. P values less than 0.05 were considered statistically significant. Prism 6 software (Graph Pad Software, Inc., La Jolla, CA) was used to analyze the data.
Results

Different Effects Between Isoflurane Plus Surgery and Desflurane Plus Surgery on Cognitive Function in AD Tg and WT Mice
The experiments were performed as demonstrated in Supplementary Fig. 1 . The baseline data of escape latency, escape distance, escape speed, escape errors and time in target quadrant of probe test of Barnes maze among the control condition, isoflurane plus surgery, and desflurane plus surgery were not significantly different (Supplemental Fig. 2) . Moreover, there were no significant differences in the escape latency, escape distance, escape speed, escape errors, and time in target quadrant of between the AD Tg and WT mice in control and the mice in anesthesia/surgery group in the Barnes maze training test (Supplemental Fig. 3 ). Two-way ANOVAwith repeated measurement showed significant interaction of treatment (isoflurane plus surgery or desflurane plus surgery versus control condition) and time (days before and after the anesthesia/surgery) on escape latency of the AD Tg mice in the Barnes maze probe test (F = 1.852, P = 0.033, Fig. 1a) . Specifically, the isoflurane plus surgery, but not desflurane plus surgery, significantly increased the escape latency of the AD Tg mice in the Barnes maze probe test as compared to the control condition at 28 days (adjusted P = 0.034, left part of Supplementary Table 1) after the anesthesia/surgery (Fig. 1a) . Note that the AD Tg mice in both control group and isoflurane plus surgery group could have lost the memory obtained from Barnes maze training at 35 and 42 days after the anesthesia/surgery as evidenced by the longer escape latency the mice had. Neither the isoflurane plus surgery nor the desflurane plus surgery increased escape latency of the WT mice in the Barnes maze probe test as compared to the control condition (F = 1.240, P = 0.247, two-way ANOVA, Fig. 1b) .
Similarly, there was a significant interaction of treatment (isoflurane plus surgery or desflurane plus surgery versus control condition) and time (days before and after the anesthesia/ surgery) on escape distance of the AD Tg mice in the Barnes maze probe test (F = 2.060, P = 0.015, two-way ANOVA, Fig.  1c ). Isoflurane plus surgery, but not desflurane plus surgery, increased escape distance of the AD Tg mice in the Barnes maze test (adjusted P = 0.011, right part of Supplemental Table 1 ). The isoflurane plus surgery or the desflurane plus surgery did not significantly change the escape distance of the WT mice in the Barnes maze probe test as compared to the control condition (F = 0.372, P = 0.982, two-way ANOVA, Fig. 1d) .
However, the two-way ANOVA with repeated measurement showed no significant interaction of treatment (isoflurane plus surgery or desflurane plus surgery versus control condition) and time (days before and after the anesthesia/surgery) on escape speed of the AD Tg mice (Fig. 1e ) and WT mice (Fig.  1f) in the Barnes maze probe test. These data suggest that the anesthesia/surgery did not impair the locomotor activity in the mice. These treatments did not significantly affect the escape errors and time in target quadrant of both AD Tg and WT mice in the Barnes maze probe test (Fig. 1g-j) .
Finally, the AD Tg mice had longer baseline escape latency of Barnes maze probe test and higher brain Aβ levels as compared to WT mice ( Supplementary Fig. 4) . Collectively, these data suggest that isoflurane plus surgery, but not the desflurane plus surgery, induced longer escape latency and escape distance, detected in Barnes maze probe test, in the AD Tg, but not the WT, mice, without impairment of locomotor activity. The isoflurane plus surgery selectively increased the escape latency and escape distance, but not escape errors or time in target quadrant, of the AD Tg mice in the Barnes maze probe test, but not training test.
Different Effects Between Isoflurane Plus Surgery and Desflurane Plus Surgery on Levels of Synaptic Markers in Hippocampus of AD Tg and WT Mice
The immunoblotting of PSD-95 revealed visible decreases in density of the bands representing PSD-95 following isoflurane plus surgery (lanes 4 to 6), but not desflurane plus surgery (lanes 7 to 9), as compared to control condition (lanes 1 to 3) (Fig. 2a) . The quantification of the Western blot, based on the ratio of PSD-95 to β-actin, showed that the isoflurane plus surgery (black bar), but not desflurane plus surgery (gray bar), significantly decreased the levels of PSD-95 in the hippocampus of AD Tg mice as compared to the control condition (white bar) (F = 6.312, P = 0.010, one-way ANOVA, Fig.  2b) . Similarly, the quantitative Western blot showed that the isoflurane plus surgery (lanes 4 to 6 in Fig. 2c and black bar in Fig. 2d ), but not desflurane plus surgery (lanes 7 to 9 in Fig. 2c and gray bar in Fig. 2d ), decreased the levels of SVP in the hippocampus of the AD Tg mice as compared to the control condition (lanes 1 to 3 in Fig. 2c and white bar in Fig. 2d ) (F = 8.012, P = 0.004, one-way ANOVA).
However, neither isoflurane plus surgery (lanes 4 to 6, black bar) nor desflurane plus surgery (lanes 7 to 9, gray bar) significantly altered the levels of PSD-95 (Fig. 2e, f) or SVP (Fig. 2g, h ) in the hippocampus of WT mice.
Different Effects Between Isoflurane Plus Surgery and Desflurane Plus Surgery on ATP Levels in Hippocampus of AD Tg and WT Mice
Isoflurane plus surgery (black bar in Fig. 3a) , but not desflurane plus surgery (gray bar in Fig. 3a) , decreased ATP levels in hippocampus of AD Tg mice as compared to control condition (white bar in Fig. 3a ) (F = 6.224, P = 0.011, one-way ANOVA). Interestingly, the isoflurane plus surgery (black bar in Fig. 3b ), but not desflurane plus surgery (gray bar in Fig. 3b) , also decreased ATP levels in hippocampus of WT mice as compared to control condition (white bar in Fig. 3b ) (F = 5.522, P = 0.016, one-way ANOVA).
Vitamin K 2 Mitigated the Longer Escape Latency and Distance of Barnes Maze Probe Test and Reductions in the Levels of Hippocampus Synaptic Markers and ATP Induced by Isoflurane Plus Surgery in AD Tg Mice
We found that the isoflurane plus surgery still induced longer escape latency of Barnes maze probe test as compared to control condition on day 28 after the anesthesia/surgery in a different group of AD Tg mice pretreated with corn oil (the vehicle of vitamin K 2 ) (Fig. 4a, F = 2 .647, P = 0.028, twoway ANOVA). However, the isoflurane plus surgery no longer increased escape latency in the AD Tg mice pretreated with vitamin K 2 (Fig. 4b , F = 0.973, P = 0.439, two-way ANOVA). Consistently, the isoflurane plus surgery increased escape distance of Barnes maze probe test as compared to control condition in the AD Tg mice pretreated with corn oil (Fig. 4c, F = 3 .922, P = 0.003, two-way ANOVA) but not vitamin K 2 (Fig. 4d , F = 1.151, P = 0.340, two-way ANOVA). In addition, these treatments did not significantly affect the escape speed of Barnes maze probe test (Fig. 4e, f) . Finally, the isoflurane plus surgery did not significantly alter the escape errors and time in target quadrant of Barnes maze probe test as compared to the control condition in the AD Tg mice with pretreatment of corn oil or vitamin K 2 ( Fig. 4g-j) .
There were no differences in the escape latency, escape distance, escape speed, escape errors, and time in target quadrant between the mice in control group and the mice in the anesthesia/surgery group in the Barnes maze training test (Supplemental Fig. 5 ). These data demonstrated again that the isoflurane plus surgery was able to induce longer escape latency and distance of Barnes maze probe test in AD Tg mice and suggest that vitamin K 2 may mitigate the cognitive changes induced by isoflurane plus surgery in the AD Tg mice. In the interaction studies, we only assessed the cognitive function up to 28 days in the mice because isoflurane plus surgery increased neither escape latency nor escape distance at 35 or 42 days after the anesthesia/surgery (Fig. 1) .
Next, we found that vitamin K 2 (lanes 10 to 12 in Fig. 5a and striped black bar in Fig. 5b ) specifically mitigated the isoflurane plus surgery-induced reduction in hippocampus PSD-95 levels (lanes 7 to 9 in Fig. 5a and black bar in Fig.  5b ) in the AD Tg mice (F = 7.837, P = 0.011, two-way ANOVA). The isoflurane plus surgery plus corn oil (lanes 7 to 9 in Fig. 5a and black bar in Fig. 5b ) decreased the hippocampus PSD-95 levels of AD Tg mice as compared to the control condition plus corn oil (lanes 1 to 3 in Fig. 5a and white bar in Fig. 5b) . Similarly, vitamin K 2 mitigated the isoflurane plus surgery-induced reduction in hippocampus SVP levels in the AD Tg mice (Fig. 5c, d) .
Finally, two-way ANOVA showed significant interaction of treatment (corn oil and vitamin K 2 ) and group (control condition versus isoflurane plus surgery), and vitamin K 2 (striped black bar in Fig. 5e ) specifically mitigated the reduction in hippocampus ATP levels induced by isoflurane plus surgery (black bar in Fig. 5e ) (F = 4.527, P = 0.046, two-way ANOVA) in the AD Tg mice.
Discussion
Isoflurane plus surgery, but not desflurane plus surgery, induced longer escape latency and distance of Barnes maze probe test in AD Tg, but not WT, mice (Figs. 1 and 4) . The findings that the anesthesia/surgery did not significantly affect escape speed suggest that the anesthesia/surgery did not impair the locomotor activity and that the observed longer escape latency and distance of Barnes maze probe test following the anesthesia/surgery was not the result of the changes in locomotor activity (Figs. 1 and 4) . These results could promote clinical investigation to determine whether there are different cognitive outcomes between the patients who have surgery under isoflurane anesthesia and the patients who have surgery under desflurane anesthesia. Ultimately, these efforts could identify better anesthetic (e.g., desflurane versus isoflurane) for AD patients and the senior patients (who are more vulnerable to develop cognitive deficiency) when surgery becomes necessary.
Interestingly, we did not demonstrate that isoflurane plus surgery-induced cognitive deficiency in adult WT male mice. These data were different from the findings that surgery under general or local anesthesia could induce cognitive impairment in rodents [19] [20] [21] [22] [23] [24] [25] [26] [27] . The potential explanations include that the mice used in the current experiments were male adult mice. It is possible that the anesthesia/surgery only induces cognitive impairment in female but not male WT mice, which is supported by our recent findings [55] .
Furthermore, our previous studies demonstrated that surgery under local anesthesia only induced cognitive impairment in WT aged mice (18-month-old), but not WT adult mice (9-month-old mice) [26, 27] , which were consistent with the Fig. 1 Isoflurane plus surgery and desflurane plus surgery differently affected cognitive function of mice in AD Tg and WT mice. a Twoway ANOVA with repeated measurement showed significant interaction (F = 1.852, P = 0.033) of treatment (isoflurane plus surgery or desflurane plus surgery versus control condition) and time (days) on escape latency of Barnes maze probe test in the AD Tg mice. The isoflurane plus surgery, but not desflurane plus surgery, significantly increased the escape latency in Barnes maze probe test as compared to control condition on day 28 after the anesthesia/surgery in the AD Tg mice. b Two-way ANOVA with repeated measurement showed no significant interaction (F = 1.240, P = 0.247) of treatment (isoflurane plus surgery or desflurane plus surgery versus control condition) and time (days) on escape latency of Barnes maze probe test in the WT mice. c Two-way ANOVA with repeated measurement showed significant interaction (F = 2.060, P = 0.015) of treatment (isoflurane plus surgery or desflurane plus surgery versus control condition) and time (days) on escape distance of Barnes maze probe test in the AD Tg mice. The isoflurane plus surgery, but not desflurane plus surgery, significantly increased the escape distance in Barnes maze probe test as compared to control condition on day 28 after the anesthesia/surgery in the AD Tg mice. d Two-way ANOVA with repeated measurement showed no significant interaction (F = 0.372, P = 0.982) of treatment (isoflurane plus surgery or desflurane plus surgery versus control condition) and time (days) on escape distance of Barnes maze probe test in the WT mice. e Two-way ANOVA with repeated measurement showed no significant interaction (F = 0.969, P = 0.486) of treatment (isoflurane plus surgery or desflurane plus surgery versus control condition) and time (days) on escape speed of Barnes maze probe test in the AD Tg mice. f Two-way ANOVA with repeated measurement showed no significant interaction (F = 1.015, P = 0.439) of treatment (isoflurane plus surgery or desflurane plus surgery versus control condition) and time (days) on escape speed of Barnes maze probe test in the WT mice. Two-way ANOVA with repeated measurement showed no significant interaction of treatment (isoflurane plus surgery or desflurane plus surgery versus control condition) and time (days) on escape errors (g and h) and time in target quadrant (i and j) in AD Tg (g and i) and WT (h and j) mice. ANOVA, analysis of variance; AD, Alzheimer's disease; Tg, transgenic; WT, wild-type. N = 12 in each group findings observed in the current studies that anesthesia/ surgery did not induce cognitive changes in WT adult mice (5-month-old). Nevertheless, the data obtained from the current studies demonstrated that desflurane plus surgery is associated with less cognitive changes than isoflurane plus surgery in both AD Tg mice and WT mice, as evidenced that the isoflurane plus surgery, but not desflurane plus surgery, induced a borderline increase of escape latency in Barnes maze probe test at 14 days (adjusted P = 0.088, Supplementary Table 1) after the anesthesia/surgery in the WT mice.
Interestingly, the observed longer escape latency and distance of Barnes maze probe test in the AD Tg mice following the isoflurane plus surgery did not occur until 28 days after the anesthesia/surgery (Fig. 1) . The reason why the anesthesia/ surgery may induce late-onset cognitive changes in the AD Tg mice is unknown at the present time. The possible explanations include that the anesthesia/surgery could initially reduce brain energy levels, which then induce a time-dependent reduction in synapse, leading to cognitive changes. We will use the established system in the current studies to perform a time course study to assess whether the anesthesia/surgery induces a maximal reduction of synapse at 28 days after the anesthesia/surgery.
Future studies may also include investigation of potential longer-term effects of anesthesia plus surgery on cognitive function in both AD Tg and WT mice. Specifically, we may need to study whether exposure of different anesthesia (e.g., isoflurane versus desflurane) plus surgery in different age (e.g., 6-, 60-, and 270-day-old) of AD Tg or WT mice can cause cognitive changes and promote AD neuropathogenesis in the mice when they grow older (e.g., 540-day-old). Ultimately, these efforts would lead to facilitate the development of strategic approach to reduce the incidence of AD and to lessen the severity of AD symptoms.
Previous studies have shown that isoflurane and desflurane have different effects on intracellular calcium levels [56] , mitochondrial function [16, 17] , and behavioral changes [16] . These differences may also contribute to the observed changes in the current studies that the surgery under isoflurane, but not desflurane, induces longer escape latency and distance of Barnes maze test in the AD Tg mice.
Bianchi et al. reported that anesthesia with 0.8 to 1% isoflurane in 30% oxygen for 2 h daily for 5 days did not induce cognitive impairment, assessed in Morris Water Maze, in 12-month-old AD Tg mice (Tg2576) [18] . These studies were different from the current studies in anesthesia (0.8 to 1% isoflurane in 30% oxygen for 2 h daily for 5 days versus 1.4% isoflurane 100% oxygen for 2 h), AD Tg mice (Tg2576 versus 5XFAD), behavioral test (Morris Water Maze versus Barnes maze), and surgery in the mice (absence versus presence). These differences could contribute to the different Fig. 3 Isoflurane plus surgery and desflurane plus surgery differently changed the ATP levels in the hippocampus of AD Tg and WT mice. a Studies showed that the isoflurane plus surgery (black bar), but not desflurane plus surgery (gray bar), significantly decreased ATP levels in hippocampus of AD Tg mice as compared to control condition (white bar) at the end of the anesthesia/surgery. b Studies showed that the isoflurane plus surgery (black bar), but not desflurane plus surgery (gray bar), significantly decreased ATP levels in hippocampus of WT mice as compared to control condition (white bar) at the end of the anesthesia/surgery. AD, Alzheimer's disease; Tg, transgenic; WT, wildtype; ATP, adenosine triphosphate. N = 6 in each group. The experiments to assess the effects of anesthesia and surgery on the levels of ATP were performed immediately at the end of the anesthesia plus surgery Fig. 2 Isoflurane plus surgery and desflurane plus surgery differently changed the levels of PSD-95 and SVP in hippocampus of AD Tg and WT mice. Isoflurane plus surgery (lanes 4 to 6), but not desflurane plus surgery (lanes 7 to 9), decreased PSD-95 (a) or SVP (c) levels in hippocampus of AD Tg mice as compared to control condition (lanes 1 to 3). There was no significant difference in β-actin levels among the various groups. Quantification of Western blot showed that the isoflurane plus surgery (black bar), but not desflurane plus surgery (gray bar), significantly decreased PSD-95 (b) or SVP (d) levels in the hippocampus of AD Tg mice as compared to control condition (white bar). Isoflurane plus surgery (lanes 4 to 6) or desflurane plus surgery (lanes 7 to 9) did not significantly decrease PSD-95 (e) or SVP (g) levels in the hippocampus of WT mice as compared to control condition (lanes 1 to 3) . There was no significant difference in β-Actin levels among the various groups. Quantification of Western blot showed that isoflurane plus surgery (black bar) or desflurane plus surgery (gray bar) did not significantly decrease PSD-95 (f) or SVP (h) levels in the hippocampus of WT mice as compared to control condition (white bar). AD, Alzheimer's disease; Tg, transgenic; WT, wild-type; PSD-95, postsynaptic density-95; SVP, synaptophysin. N = 6 in each group. The experiments to assess the effects of anesthesia and surgery on the levels of PSD-95 and SVP were performed on day 42 after the anesthesia plus surgery behaviors (no cognitive changes versus cognitive changes) observed between the studies by Bianchi et al. and the current studies.
We found that the isoflurane plus surgery, but not desflurane plus surgery, decreased the levels of synaptic marker PSD-95 [30, 31] and SVP [32] in the hippocampus of AD Tg mice but not WT mice (Fig. 2) . These cellular changes further suggest the different effects of isoflurane plus surgery versus desflurane plus surgery. However, the underlying mechanisms why isoflurane, but not desflurane, plus surgery decreased the hippocampus levels of PSD-95 and SVP of AD Tg mice remain to be determined in the future.
Consistently, the isoflurane plus surgery, but not desflurane plus surgery, reduced the hippocampus ATP levels in the mice. Taken together, these data suggest the potential mechanistic cascade that anesthesia/surgery induced ATP reduction, which may then cause reduction in synapse, consequently leading to cognitive changes. More importantly, the current studies have established a system to dissect the cascade in the future investigations. However, we did not examine the dynamic changes of brain ATP levels in the current studies; thus, the correlation between brain energy and cognitive function in the mice needs to be further tested in the future.
Interestingly, the isoflurane plus surgery decreased hippocampus ATP levels but did not cause cognitive changes in the WT mice. These observations could be due to the fact that WT mice may have more brain or cognitive reserve and the initial reduction in hippocampus ATP levels may not cause sufficient reduction in hippocampus synapse, thus not causing cognitive changes in the WT mice. At the present time, we only showed that the combination of anesthesia and surgery reduced ATP levels in brain tissues (hippocampus) in the mice. Our future studies will assess the extent to which the anesthesia/surgery reduces ATP levels in neurons or microglia via mitochondrial dysfunction.
Finally, vitamin K 2 was able to mitigate the isoflurane plus surgery-induced longer escape latency and distance of Barnes maze probe test and reduction in the levels of synaptic markers and ATP in AD Tg mice (Figs. 4 and 5 ). These data further support the hypothesized pathway of the anesthesia/surgeryinduced changes in cognitive function. More importantly, these results may promote clinical investigation to determine whether vitamin K 2 can treat the anesthesia/surgery-induced cognitive impairment in AD patients.
Vitamin K 2 has been shown to have neuroprotective effects [33] [34] [35] through serving as a mitochondrial electron carrier and energy enhancer [33] . The anesthesia/surgery reduced ATP levels and induced longer escape latency and distance of Barnes maze probe test in the AD Tg mice. Collectively, the findings that vitamin K 2 mitigated the anesthesia/surgeryinduced both ATP reduction and longer escape latency and distance of Barnes maze probe test suggest that brain energy deficits may contribute to the longer escape latency and distance of Barnes maze probe test and vitamin K 2 may improve cognitive function through enhancing brain energy levels, pending further investigation.
The isoflurane plus surgery-induced longer escape latency and distance of Barnes maze probe test at 28 days after the anesthesia/surgery. But the effects of anesthesia/surgery on the levels of PSD-95 and SVP were determined at the 42 days after the anesthesia/surgery. This is because AD Tg mice are expensive and we only had limited supply of AD Tg mice; thus, we did not use separate group of AD Tg mice for behavior and Western blot studies. Rather, we performed the Barnes maze probe test every 7 days after the anesthesia/surgery up to 42 days and then harvested the brain tissues of these AD Tg mice at the end of the behavior studies for the Western blot analysis (Fig. 2) . Nevertheless, in the rescue studies of vitamin K 2 , we indeed demonstrated that isoflurane plus surgery reduced levels of PSD-95 and SVP at the 28 days after the anesthesia/surgery (Fig. 5) , which was accompanied by the findings the same isoflurane plus surgery-induced longer escape latency and distance of Barnes maze probe test at the 28 days after the anesthesia/surgery (Fig. 4) . Fig. 4 Vitamin K 2 mitigated the cognitive deficiency induced by isoflurane plus surgery in AD Tg mice. a Two-way ANOVA with repeated measurement showed significant interaction (F = 2.647, P = 0.028) of treatment (isoflurane plus surgery versus control condition) and time (days) on escape latency of Barnes maze probe test in AD Tg mice pretreated with corn oil (the vehicle of vitamin K 2 ). Specifically, the isoflurane plus surgery significantly increased the escape latency of Barnes maze probe test as compared to control condition in the AD Tg mice on day 28 after the anesthesia/surgery. b Two-way ANOVA with repeated measurement showed no significant interaction (F = 0.973, P = 0.439) of treatment (isoflurane plus surgery versus control condition) and time (days) on escape latency of Barnes maze probe test in the AD Tg mice pretreated with vitamin K 2 . c Twoway ANOVA with repeated measurement showed significant interaction (F = 3.922, P = 0.003) of treatment (isoflurane plus surgery versus control condition) and time (days) on escape distance of Barnes maze probe test in AD Tg mice pretreated with corn oil (the vehicle of vitamin K 2 ). Specifically, the isoflurane plus surgery significantly increased the escape distance of Barnes maze probe test as compared to control condition in the AD Tg mice on day 28 after the anesthesia/surgery. d Two-way ANOVA with repeated measurement showed no significant interaction (F = 1.151, P = 0.340) of treatment (isoflurane plus surgery versus control condition) and time (days) on escape distance of Barnes maze probe test in the AD Tg mice pretreated with vitamin K 2 . e Twoway ANOVA with repeated measurement showed no significant interaction (F = 0.283, P = 0.921) of treatment (isoflurane plus surgery versus control condition) and time (days) on escape speed of Barnes maze probe test in AD Tg mice pretreated with corn oil (the vehicle of vitamin K 2 ). f Two-way ANOVA with repeated measurement showed no significant interaction (F = 0.670, P = 0.648) of treatment (isoflurane plus surgery versus control condition) and time (days) on escape speed of Barnes maze probe test in the AD Tg mice pretreated with vitamin K 2 . Two-way ANOVA with repeated measurement showed no significant interaction of treatment (isoflurane plus surgery versus control condition) and time (days) on escape errors (g and h) and time in target quadrant (i and j) in AD Tg mice with pretreatment of corn oil (g and i) or vitamin K 2 (h and j). ANOVA, analysis of variance; AD, Alzheimer's disease; Tg, transgenic. N = 10 in each group
The levels of SVP and PSD-95 decreased to the same extent at day 28 and day 42 following isoflurane plus surgery, but the isoflurane plus surgery only induced behavioral changes at day 28, but not day 42. The exact reason underlying this observation is unknown at the present time. However, the escape latency and escape distance of the AD Tg mice on 3) . Vitamin K 2 plus isoflurane plus surgery (lanes 10 to 12) led to lesser reductions of levels of PSD-95 (a) or SVP (c) as compared to corn oil plus isoflurane plus surgery (lanes 7 to 9). Quantification of Western blot showed that vitamin K 2 (striped black bar) inhibited the reduction in levels of PSD-95 (b) or SVP (d) induced by the isoflurane plus surgery (black bar). e ELISA showed that corn oil plus isoflurane plus surgery (black bar) significantly decreased ATP levels in hippocampus of AD Tg mice as compared to corn oil plus control condition (white bar) at the end of the anesthesia/surgery. Treatment with vitamin K 2 alone (white striped bar) did not significantly change ATP levels as compared to control condition plus corn oil (white bar). However, there was a significant interaction of vitamin K 2 and isoflurane plus surgery on ATP levels, and vitamin K 2 mitigated the reductions in ATP levels induced by the isoflurane plus surgery in the AD Tg mice. AD, Alzheimer's disease; Tg, transgenic; ATP, adenosine triphosphate. N = 6 in each group. The experiments to assess the effects of anesthesia and surgery on the levels of PSD-95 and SVP were performed on day 28 after the anesthesia plus surgery. The experiments to assess the effects of anesthesia and surgery on the levels of ATP were performed immediately at the end of the anesthesia plus surgery days 28 and 42 following isoflurane plus surgery were at similar levels (Fig. 1a, c) , which was consistent with the findings that the levels of SVP and PSD-95 decreased to the same extent at day 28 and day 42 following the isoflurane plus surgery. At the day 42 after the control condition, the AD Tg mice had increased escape latency and escape distance as compared to those at baseline, which contributed to the fact that there was no significant difference on escape latency and distance between control condition and isoflurane plus anesthesia on day 42 after the control condition or isoflurane plus anesthesia. The increases of escape latency and escape distance in AD Tg mice following the control condition could be due to the fact that the AD Tg mice forgot the initial training in the Barnes maze. The future studies should test this hypothesis to further adjust our established system to better assess the effects of anesthesia plus surgery on cognitive function in AD Tg mice.
Interestingly, the isoflurane plus surgery only increased the escape latency and escape distance in the AD Tg mice (Fig. 1 ) without significant changes in escape errors and the time in target quadrant (Fig. 1) . Increased escape latency and escape distance may reflect an increased exploratory behavior or avoidance of closed areas [57] . Therefore, the limitation of the present study is that the findings that isoflurane plus surgery increased escape latency and escape distance might not be sufficient enough to demonstrate that the isoflurane plus surgery-induced cognitive impairment. However, many other studies suggest that increased escape latency and escape distance without significant alterations in escape errors and the time in target quadrant also indicate cognitive impairment in rodents [46] [47] [48] [58] [59] [60] [61] [62] [63] . Moreover, the increased exploratory behavior described in the literature did not appear in the 5xFAD mice until 12-month-old [57] , and we only used 5-month-old 5xFAD mice in the current studies. Finally, the major objective of the current study was to compare the effects of isoflurane plus surgery versus desflurane plus surgery on animal behavior changes. Nevertheless, the future studies should include the experiments to assess the effects of anesthesia plus surgery on cognitive function in AD Tg mice employing other behavior models (e.g., Fear Conditioning System and Morris Water Maze) in addition to Barnes maze.
The current studies have other limitations. First, we did not systematically investigate the effects of different treatment of isoflurane and desflurane (dosage and time) plus surgery on cognitive deficiency and the associated cellular mechanism. However, the data demonstrated the difference between the clinical relevant concentrations of isoflurane plus surgery and desflurane plus surgery. Second, we did not determine the effects of the anesthesia/surgery on brain levels of Aβ and phosphorylated Tau protein. This is because previous studies have revealed that anesthesia and/or surgery can increase brain levels of Aβ and phosphorylated Tau protein [23, 26, 37] . Third, we only used male AD Tg mice in the studies, thus the outcomes may not imply for female AD patients. Finally, we did not know whether the reduction in brain ATP levels could directly lead to decreased levels of PSD-95 and SVP. However, the findings that vitamin K 2 attenuated the anesthesia/surgery-induced reduction in both ATP levels and levels of PSD-95 and SVP as well as behavioral changes suggest the potential association of ATP, synapse and cognitive changes.
In conclusion, we showed that the commonly used inhalation anesthetic isoflurane plus surgery could induce cognitive impairment (e.g., longer escape latency and distance of Barnes maze probe test) and reductions in hippocampus levels of ATP and synaptic markers in male AD Tg mice but not in male WT mice. However, another commonly used inhalation anesthetic desflurane plus surgery did not induce these changes in the mice. Moreover, vitamin K 2 could mitigate the longer escape latency and distance of Barnes maze probe test and reduction in hippocampus levels of ATP and synaptic markers induced by the isoflurane plus surgery. These findings should promote clinical investigation to determine whether desflurane plus surgery is less associated with cognitive impairment than isoflurane plus surgery in AD patients and whether vitamin K 2 can prevent or treat postoperative cognitive dysfunction in AD and senior patients. Pending further animals and clinical investigations, these findings would suggest that desflurane could be a better choice for AD patients and other senior patients who are vulnerable to the development of postoperative cognitive impairment.
